BRIEF published on 03/11/2026 at 17:50, 7 months 18 days ago Mauna Kea Technologies Achieves Milestone with CLIMB Study Mauna Kea Technologies Cellvizio Pancreatic Cysts CLIMB Study ASGE Plenary Session
PRESS RELEASE published on 03/11/2026 at 17:45, 7 months 18 days ago Inside Information / Other news releases Mauna Kea Technologies announces CLIMB study for Cellvizio® in Pancreatic Cysts selected for ASGE Presidential Plenary Session at DDW 2026, showcasing superior diagnostic accuracy and clinical impact Mauna Kea Technologies Cellvizio Pancreatic Cysts CLIMB Study ASGE
BRIEF published on 02/10/2026 at 17:50, 8 months 19 days ago Mauna Kea Technologies Secures CE MDR Certification for Cellvizio® Cellvizio Clinical Expansion CE MDR Certification European Commercialization MedTech Regulation
BRIEF published on 02/10/2026 at 17:50, 8 months 19 days ago Mauna Kea Technologies obtient la certification CE MDR pour Cellvizio® Cellvizio Expansion Clinique Certification CE MDR Commercialisation Européenne Réglementation Des Technologies Médicales
PRESS RELEASE published on 02/10/2026 at 17:45, 8 months 19 days ago Inside Information / Other news releases Mauna Kea Technologies announces CE MDR certification for Cellvizio and probes, marking a key milestone in their European expansion strategy under new regulation Mauna Kea Technologies Cellvizio Regulatory Milestone CE MDR Certification European Expansion Strategy
BRIEF published on 01/21/2026 at 17:50, 9 months 8 days ago Mauna Kea Technologies : Agenda financier 2026 dévoilé Calendrier Financier Conférences Investisseurs Mauna Kea Technologies Cellvizio Stratégies De Croissance
BRIEF published on 01/21/2026 at 17:50, 9 months 8 days ago Mauna Kea Technologies: 2026 Financial Calendar Unveiled Investor Conferences Financial Calendar Growth Strategies Mauna Kea Technologies Cellvizio
PRESS RELEASE published on 01/21/2026 at 17:45, 9 months 8 days ago Informations privilégiées / Autres communiqués Mauna Kea Technologies annonce son agenda financier 2026 et sa participation à des forums investisseurs pour présenter ses avancées. La société reprend sa communication après une restructuration en 2025 Partenariats Stratégiques Agenda Financier Mauna Kea Technologies Cellvizio Forums Investisseurs
BRIEF published on 11/20/2025 at 17:50, 11 months 9 days ago Mauna Kea's Cellvizio Gen 3 receives approval in China NMPA Approval Chinese Market Mauna Kea Cellvizio Gen 3 Endoscopy
BRIEF published on 11/20/2025 at 17:50, 11 months 9 days ago Approbation du Cellvizio Gen 3 de Mauna Kea en Chine Marché Chinois Mauna Kea Cellvizio Gen 3 Approbation NMPA Endoscopie
Published on 10/29/2026 at 22:01, 12 hours ago Pinetree Capital Announces Unaudited Financial Results for the Period Ended September 30, 2026
Published on 10/29/2026 at 21:30, 12 hours 31 minutes ago Shelfie Announces Amendments to Previously Announced Acquisition of Aspect
Published on 10/29/2026 at 18:30, 15 hours 31 minutes ago Kidoz Inc. Appoints Derek Sentner as Chief Revenue Officer
Published on 10/29/2026 at 16:05, 17 hours 56 minutes ago SouthGobi Announces Date of Special Meeting of Shareholders and The Record Date
Published on 10/30/2026 at 09:49, 12 minutes ago PSI reports revenue growth and one-time expenses after nine months
Published on 10/30/2026 at 09:30, 30 minutes ago HIZENERGY Presents Full‑Range C&I BESS Solutions for European Energy Transition
Published on 10/30/2026 at 09:07, 53 minutes ago Emerald Horizon Chief Scientist Müller: Molten Salt Storage delivers up to six percent more energy
Published on 10/30/2026 at 09:05, 55 minutes ago Baseus Spacemate RD1 Plus: The Definitive 14-in-1 Desk Tower with 4K@120Hz
Published on 10/30/2026 at 08:00, 2 hours 1 minute ago Neoen secures AUD 1.8 billion in debt financing to support renewable energy portfolio in Australia
Published on 10/30/2026 at 07:00, 3 hours 1 minute ago Groupe DLSI - Chiffre d'affaires 3ème trimestre 2026
